High materiality7/10
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update indicating strong upside potential despite recent price dip; target implies significant upside.
- Target $65
- Posted price $21.75
- Analyst firm Morgan Stanley
Key facts
- 01
Target: $65
- 02
Posted price: $21.75
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.